Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI

被引:10
|
作者
Miller, Aaron C. [1 ]
Polgreen, Linnea A. [2 ]
Cavanaugh, Joseph E. [3 ]
Polgreen, Philip M. [4 ,5 ]
机构
[1] Cornell Coll, Dept Econ & Business, Mt Vernon, IA 52314 USA
[2] Univ Iowa, Dept Pharm Practice & Sci, Iowa City, IA USA
[3] Univ Iowa, Dept Biostat, Iowa City, IA USA
[4] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[5] Univ Iowa, Dept Epidemiol, 200 Hawkins Dr, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
Clostridium difficile infection; risk; health care-associated infection; environment; CARE-ASSOCIATED INFECTIONS; COSTS; DISEASE; STAY; EPIDEMIOLOGY; ACQUISITION; ENVIRONMENT; PREVALENCE; MORTALITY; PRESSURE;
D O I
10.1016/j.ajic.2016.01.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Environmental risk factors for Clostridium difficile infections (CDIs) have been described at the room or unit level but not the hospital level. To understand the environmental risk factors for CDI, we investigated the association between institutional-and individual-level CDI. Methods: We performed a retrospective cohort study using the Healthcare Cost and Utilization Project state inpatient databases for California (2005-2011). For each patient's hospital stay, we calculated the hospital CDI incidence rate corresponding to the patient's quarter of discharge, while excluding each patient's own CDI status. Adjusting for patient and hospital characteristics, we ran a pooled logistic regression to determine individual CDI risk attributable to the hospital's CDI rate. Results: There were 10,329,988 patients (26,086 cases and 10,303,902 noncases) who were analyzed. We found that a percentage point increase in the CDI incidence rate a patient encountered increased the odds of CDI by a factor of 1.182. Conclusions: As a point of comparison, a 1-percentage point increase in the CDI incidence rate that the patient encountered had roughly the same impact on their odds of acquiring CDI as a 55.8-day increase in their length of stay or a 60-year increase in age. Patients treated in hospitals with a higher CDI rate are more likely to acquire CDI. (C) 2016 Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.
引用
收藏
页码:825 / 829
页数:5
相关论文
共 50 条
  • [41] Hospital Transfer Network Structure as a Risk Factor for Clostridium difficile Infection
    Simmering, Jacob E.
    Polgreen, Linnea A.
    Campbell, David R.
    Cavanaugh, Joseph E.
    Polgreen, Philip M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (09): : 1031 - 1037
  • [42] CLOSTRIDIUM DIFFICILE INFECTION IN 2010 Advances in pathogenesis, diagnosis and management of CDI
    Gerding, Dale N.
    Johnson, Stuart
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (02) : 67 - 68
  • [43] Is Clostridium difficile infection (Cdi) more difficult to eradicate in patients with diverticulosis?
    Thanjan, Andy
    Southern, William
    Anand, Neeraj
    Yoon, Sonia
    Brandt, Lawrence
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S195 - S195
  • [44] INTRACOLONIC VANCOMYCIN (ICV) USE IN SEVERE CLOSTRIDIUM DIFFICILE INFECTION (CDI)
    Forsyth, Lisa
    Natavio, Allycia
    Villalba, Mario
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A432 - A432
  • [45] Diagnostic Value of Repeated Enzyme Immunoassays in Clostridium Difficile Infection (CDI)
    Nemat, Hashim
    Khan, Rabia
    Ashraf, Muhammad
    Matta, Mandeep
    Ahmed, Shahin
    Edwards, Barbara
    Hussain, Roshan
    Lesser, Martin
    Pekmezaris, Renee
    Dlugacz, Yosef
    Wolf-Klein, Gisele
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S179 - S179
  • [46] Patients With Ulcerative Colitis Hospitalized With Clostridium difficile Infection (CDI) Should Be Treated With Vancomycin Regardless of Cdi Severity
    Horton, Henry A.
    Dezfoli, Seper
    Berel, Dror
    Hirsch, Julianna
    Targan, Stephan R.
    Ippoliti, Andrew
    Vasiliauskas, Eric A.
    McGovern, Dermot P.
    Kaur, Manreet
    Shih, David Q.
    Dubinsky, Marla
    Fleshner, Phillip
    Grein, Jonathan
    Murthy, Rekha
    Melmed, Gil
    GASTROENTEROLOGY, 2012, 142 (05) : S123 - S123
  • [47] Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county
    Norén, T
    Åkerlund, T
    Bäck, E
    Sjöber, L
    Persson, I
    Alriksson, I
    Burman, LG
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (08) : 3635 - 3643
  • [48] Hypervirulent Clostridium difficile Strains Are Rarely Associated With Nosocomial CDI in Adults in Lebanon: Results From a Prospective Study on the Incidence, Risk Factors for Relapse, and Outcome of Nosocomial CDI
    Sharara, Ala
    Karaoui, Walid R.
    Shayto, Rani H.
    Rimmani, Hussein
    Chalhoub, Jean M.
    Zahreddine, Nada
    El Sabbagh, Rana
    Kanj, Souha S.
    Mahfouz, Rami
    Araj, George
    Rasheed, Sari
    Berger, Fabian
    Gaertner, Barbara
    Matar, Ghassan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S51 - S51
  • [49] Mandatory surveillance of severe cases of Clostridium difficile infection (CDI) in Germany
    Kleinkauf, N.
    Weiss, B.
    Jansen, A.
    Eckmanns, T.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 298 : 95 - 95
  • [50] Frequency and Impact of Clostridium Difficile Infection (CDI) in Hospitalized Patients with Cirrhosis
    Reddy, K. Rajender
    Tandon, Puneeta
    O'Leary, Jacqueline G.
    Wong, Florence
    Garcia-Tsao, Guadalupe
    Kamath, Patrick S.
    Lai, Jennifer Cindy
    Biggins, Scott W.
    Thuluvath, Paul J.
    Fallon, Michael B.
    Vargas, Hugo E.
    Subramanian, Ram M.
    Thacker, Leroy R.
    Bajaj, Jasmohan S.
    HEPATOLOGY, 2018, 68 : 1336A - 1337A